Google has launched its appeal against Brussels in a fightback over its record monopoly abuse fine. The search giant has filed an appeal to the European Commission over its €2.4bn (US$2.7 billion) antitrust penalty.
The Commission hit Google with the fine in June after finding the company had illegally abused the dominance of its search engine to promote its online shopping over smaller comparison sites. Google is facing further multi-billion euro fines from the Commission over its Android software and online advertising network.
The company filed its appeal following a victory for Intel in a separate competition case. Europe’s highest court last week said a €1.1 billion (US$1.3 billion) fine against Intel, levied in 2009, should be re-examined.
EU competition commissioner Margrethe Vestager is investigating Google in three cases, as well as tech giants Apple, Facebook and Qualcomm.
The €2.4 billion fine (US$2.7 billion, at the time it was levied) against Google for illegally exploiting its 90% search market share led to its parent company Alphabet’s profits falling by 30% in July. Google said it “respectfully disagreed” with the EU decision.
Brussels’ war against tech companies has included orders to pay large fines and unpaid tax bills. It has drawn criticism from US politicians who have accused the EU of protectionism and bias.
Google has had to change its search results or face further fines worth 50% of its turnover. The company must implement plans it submitted in August by the end of this month. Vestager said the proposals pointed “in the very right direction”, but the company will be closely monitored for a number of years.
Decisions in the Android mobile software and AdSense advertising cases are expected later this year.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas